A Study to Evaluate the Efficacy and Safety of Taldefgrobep Alfa in Participants With Spinal Muscular Atrophy
Clinical trial NCT05337553 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT05337553
- Sponsor
- Biohaven Pharmaceuticals, Inc.
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2022-07-06
- Primary completion
- 2024-09-25
- Enrollment
- 269
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.